Gallstone disease differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 60: | Line 60: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Abnormal [[LFT]] | * Abnormal [[LFT]] | ||
* WBC >10,000 | * [[WBC]] >10,000 | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows [[biliary]] dilatation/stents/tumor | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] shows [[biliary]] [[dilatation]]/[[stents]]/[[tumor]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Septic shock]] occurs with features of [[SIRS]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Septic shock]] occurs with features of [[SIRS]] | ||
|- | |- | ||
Line 77: | Line 77: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Abnormal [[LFT]] | * Abnormal [[LFT]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows [[biliary]] dilatation/stents/tumor | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] shows [[biliary]] [[dilatation]]/[[stents]]/[[tumor]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Biliary drainage ([[Endoscopic retrograde cholangiopancreatography|ERCP]]) + IV antibiotics | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Biliary]] drainage ([[Endoscopic retrograde cholangiopancreatography|ERCP]]) + IV [[antibiotics]] | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" | [[Acute cholecystitis|Acute cholecystitis]] | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" | [[Acute cholecystitis|Acute cholecystitis]] | ||
Line 94: | Line 94: | ||
* [[Hyperbilirubinemia]] | * [[Hyperbilirubinemia]] | ||
* [[Leukocytosis]] | * [[Leukocytosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows gallstone and evidence of inflammation | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] shows gallstone and evidence of [[inflammation]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Murphy's sign|Murphy’s sign]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Murphy's sign|Murphy’s sign]] | ||
|- | |- | ||
Line 111: | Line 111: | ||
* Increased [[amylase]] / [[lipase]] | * Increased [[amylase]] / [[lipase]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Ultrasound shows evidence of [[inflammation]] | * [[Ultrasound]] shows evidence of [[inflammation]] | ||
* CT scan shows severity of [[pancreatitis]] | * [[CT scan]] shows severity of [[pancreatitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Pain radiation to back | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Pain]] radiation to back | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Primary sclerosing cholangitis]] | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Primary sclerosing cholangitis]] | ||
Line 127: | Line 127: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Increased liver enzymes | * Increased [[liver enzymes]] | ||
* Increased [[IgM]], [[IgG]]4 | * Increased [[IgM]], [[IgG]]4 | ||
* [[Anti-neutrophil cytoplasmic antibody]] ([[p-ANCA]]) | * [[Anti-neutrophil cytoplasmic antibody]] ([[p-ANCA]]) | ||
Line 133: | Line 133: | ||
* [[Anti-smooth muscle antibody]] (Anti-Sm) | * [[Anti-smooth muscle antibody]] (Anti-Sm) | ||
* Anti-endothelial antibody | * Anti-endothelial antibody | ||
* Anti-cardiolipin antibody | * [[Anticardiolipin antibody|Anti-cardiolipin antibody]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Endoscopic retrograde cholangiopancreatography|ERCP]] and [[Magnetic resonance cholangiopancreatography|MRCP]] shows | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Endoscopic retrograde cholangiopancreatography|ERCP]] and [[Magnetic resonance cholangiopancreatography|MRCP]] shows | ||
* Multiple segmental [[strictures]] | * Multiple segmental [[strictures]] | ||
* Mural irregularities | * Mural irregularities | ||
* [[Biliary]] | * [[Biliary]] [[dilatation]] and [[diverticula]] | ||
* Distortion of [[biliary tree]] | * Distortion of [[biliary tree]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |The risk of [[cholangiocarcinoma]] in patients with [[primary sclerosing cholangitis]] is 400 times higher than the risk in the general population. | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |The risk of [[cholangiocarcinoma]] in patients with [[primary sclerosing cholangitis]] is 400 times higher than the risk in the general population. | ||
Line 154: | Line 154: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[Leukocytosis]] | * [[Leukocytosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows [[gallstone]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] shows [[gallstone]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Fatty food intolerance | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Fatty food intolerance | ||
|- | |- | ||
Line 170: | Line 170: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Hyperactive/hypoactive | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Hyperactive/hypoactive | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* WBC> 10,000 | * [[WBC]]> 10,000 | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Air under [[diaphragm]] in upright [[CXR]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Air under [[diaphragm]] in upright [[CXR]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Hamman's sign]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Hamman's sign]] | ||
Line 191: | Line 191: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[String sign]] on [[abdominal x-ray]] in [[Crohn's disease]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[String sign]] on [[abdominal x-ray]] in [[Crohn's disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Extra intestinal findings: | Extra [[Intestine|intestinal]] findings: | ||
* [[Uveitis]] | * [[Uveitis]] | ||
* [[Arthritis]] | * [[Arthritis]] | ||
Line 238: | Line 238: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Abnormal LFTs | * Abnormal [[LFTs]] | ||
* Viral serology | * [[Viral]] [[serology]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Hepatitis|Hep A]]and [[Hepatitis|Hep E]] have fecoral route of transmission and [[Hepatitis|Hep B]] and [[Hepatitis|Hep C]] transmits via blood transfusion and sexual contact. | * [[Ultrasound]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Hepatitis|Hep A]]and [[Hepatitis|Hep E]] have fecoral route of transmission and [[Hepatitis|Hep B]] and [[Hepatitis|Hep C]] transmits via [[blood transfusion]] and [[sexual contact]]. | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Liver mass|Liver masses]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Liver mass|Liver masses]] | ||
Line 255: | Line 256: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* CBC | * [[CBC]] | ||
* LFTs | * [[LFTs]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[Ultrasound]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
|- | |- | ||
Line 272: | Line 274: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal/hypoactive | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal/hypoactive | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* CBC | * [[CBC]] | ||
* Blood cultures | * [[Blood cultures]] | ||
* Abnormal [[Liver function test|liver function tests]] | * Abnormal [[Liver function test|liver function tests]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* | * [[Ultrasound]] | ||
* CT | * [[CT]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
|- | |- | ||
Line 297: | Line 299: | ||
* Abnormal [[Liver function test|liver function tests]] | * Abnormal [[Liver function test|liver function tests]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* | * [[Ultrasound]] | ||
* CT | * [[CT]] | ||
* Liver biopsy | * [[Liver biopsy]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Other symptoms: | Other symptoms: | ||
Line 314: | Line 316: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in liver failure leading to varices | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in [[liver failure]] leading to [[varices]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
Line 322: | Line 324: | ||
*Elevated [[Aspartate aminotransferase|serum aspartate aminotransferase]] and [[alanine aminotransferase]] levels may be more than five times the upper limit of the normal range. | *Elevated [[Aspartate aminotransferase|serum aspartate aminotransferase]] and [[alanine aminotransferase]] levels may be more than five times the upper limit of the normal range. | ||
*Elevated serum [[alkaline phosphatase]] and [[Bilirubin|bilirubin levels]], decreased [[Albumin|serum albumin level]]. | *Elevated serum [[alkaline phosphatase]] and [[Bilirubin|bilirubin levels]], decreased [[Albumin|serum albumin level]]. | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Findings on [[CT scan]] suggestive of [[Budd-Chiari syndrome]] include: | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Findings on [[CT scan]] suggestive of [[Budd-Chiari syndrome]] include: | ||
*Early enhancement of the [[caudate lobe]] and [[central liver]] around the [[Inferior vena cavae|inferior vena cava]] | *Early enhancement of the [[caudate lobe]] and [[central liver]] around the [[Inferior vena cavae|inferior vena cava]] | ||
Line 330: | Line 329: | ||
*Peripheral zones of the [[liver]] show reversed [[portal]] [[venous]] [[blood flow]] | *Peripheral zones of the [[liver]] show reversed [[portal]] [[venous]] [[blood flow]] | ||
*In the [[chronic]] phase, there is [[caudate lobe]] enlargement and [[atrophy]] of the [[Liver|peripheral liver]] in affected areas | *In the [[chronic]] phase, there is [[caudate lobe]] enlargement and [[atrophy]] of the [[Liver|peripheral liver]] in affected areas | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ascitic tap|Ascitic fluid examination]] shows: | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ascitic tap|Ascitic fluid examination]] shows: | ||
*[[Total protein]] more than 2.5 g per deciliter | *[[Total protein]] more than 2.5 g per deciliter | ||
Line 340: | Line 338: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in cirrhotic patients | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in [[cirrhotic]] patients | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
Line 351: | Line 349: | ||
* Culture: Positive for single organism | * Culture: Positive for single organism | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound for evaluation of | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] for evaluation of [[liver cirrhosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
|- | |- |
Revision as of 15:46, 15 December 2017
Gallstone disease Microchapters |
Diagnosis |
---|
Treatment |
Surgery |
Case Studies |
Gallstone disease differential diagnosis On the Web |
American Roentgen Ray Society Images of Gallstone disease differential diagnosis |
Risk calculators and risk factors for Gallstone disease differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]
Overview
Gallstone disease must be differentiated from other diseases that cause right upper quadrant pain including gastroesophageal reflux disorder, peptic ulcer disease,hepatitis,sphincter of Oddi dysfunction,appendicitis, bile duct stricture, chronic pancreatitis, irritable bowel syndrome, ischemic heart disease, pyelonephritis, ureteral calculi and complications of gallstone disease include: acute cholecystitis, choledocholithiasis, acute pancreatitis, and acute cholangitis.
Differentiating Gallstone disease from other Diseases
- Gallstone disease can manifest in a variety of clinical forms.
- The presence of biliary colic is an important diagnostic feature to distinguish between gallstones and non-biliary stone disorders.
- Patients who present with biliary colic are more likely to have gallstones detected on imaging. [1]
- However, it is important to note that biliary colic can be concomitant in patients with other biliary disorders such as acute cholecystitis, choledocholithiasis, sphincter of Oddi dysfunction, and functional gallbladder disorder.[2][3]
Differential diagnosis
The differential diagnosis of diseases presenting with abdominal pain, fever and jaundice is discussed below.
Abbreviations: RUQ= Right upper quadrant of the abdomen, LUQ= Left upper quadrant, LLQ= Left lower quadrant, RLQ= Right lower quadrant, LFT= Liver function test, SIRS= Systemic inflammatory response syndrome, ERCP= Endoscopic retrograde cholangiopancreatography, IV= Intravenous, N= Normal, AMA= Anti mitochondrial antibodies, LDH= Lactate dehydrogenase, GI= Gastrointestinal, CXR= Chest X ray, IgA= Immunoglobulin A, IgG= Immunoglobulin G, IgM= Immunoglobulin M, CT= Computed tomography, PMN= Polymorphonuclear cells, ESR= Erythrocyte sedimentation rate, CRP= C-reactive protein, TS= Transferrin saturation, SF= Serum Ferritin, SMA= Superior mesenteric artery, SMV= Superior mesenteric vein, ECG= Electrocardiogram
|
To review a differential diagnosis for abdominal pain, click here
References
- ↑ Kraag N, Thijs C, Knipschild P (1995). "Dyspepsia--how noisy are gallstones? A meta-analysis of epidemiologic studies of biliary pain, dyspeptic symptoms, and food intolerance". Scand. J. Gastroenterol. 30 (5): 411–21. PMID 7638565.
- ↑ Portincasa P, Moschetta A, Palasciano G (2006). "Cholesterol gallstone disease". Lancet. 368 (9531): 230–9. doi:10.1016/S0140-6736(06)69044-2. PMID 16844493.
- ↑ Center SA (2009). "Diseases of the gallbladder and biliary tree". Vet. Clin. North Am. Small Anim. Pract. 39 (3): 543–98. doi:10.1016/j.cvsm.2009.01.004. PMID 19524793.